Foster Dykema Cabot & Partners, LLC Roivant Sciences Ltd. Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.19 Trillion
- Q3 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 72 shares of ROIV stock, worth $860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72Holding current value
$860% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
319Shares Held
524MCall Options Held
1.3MPut Options Held
1.09M-
Viking Global Investors LP69.2MShares$826 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$797 Million72.99% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$788 Million6.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$498 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$423 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.42B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...